Speciality Medi.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
159.95
5.15 (3.33%)
BSENSE

Nov 20

BSE+NSE Vol: 15000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 29.20% vs 111.71% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 49.85% vs 73.16% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 158.48% vs -17.20% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 81.11% vs 145.30% in Mar 2025

Compare Profit and Loss Results of Speciality Medi.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
75.00
106.00
-31.00
-29.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
75.00
106.00
-31.00
-29.25%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
1.00
-11.00
-1,100.00%
Raw Materials Consumed
65.00
69.00
-4.00
-5.80%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
8.00
-7.00
-87.50%
Operating Expenses
0.00
7.00
-7.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
1.00
1.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
61.00
93.00
-32.00
-34.41%
Operating Profit (PBDIT) excl Other Income
13.00
13.00
0.00
0.00%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
14.00
17.00
-3.00
-17.65%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
13.00
16.00
-3.00
-18.75%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
13.00
14.00
-1.00
-7.14%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
14.00
-1.00
-7.14%
Provision for Tax
0.00
3.00
-3.00
-100.00%
Profit After Tax
13.00
10.00
3.00
30.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
13.00
63.00
-50.00
-79.37%
Profit Available for appropriations
26.00
74.00
-48.00
-64.86%
Appropriations
26.00
74.00
-48.00
-64.86%
Equity Dividend (%)
0%
32%
-32.00
Earnings Per Share
14.9
8.22
6.68
81.27%
Profit And Loss - Net Sales
Net Sales 75.29 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 29.20% vs 111.71% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.85% vs 73.16% in Mar 2025

Profit And Loss - Interest
Interest 1.32 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 158.48% vs -17.20% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 13.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 81.11% vs 145.30% in Mar 2025